Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
-2.13M
-
Total reported value, excl. options
-
$32.1M
-
Value change
-
-$6.9M
-
Put/Call ratio
-
0
-
Number of buys
-
13
-
Number of sells
-
-23
-
Price
-
$2.75
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q4 2023
61 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q4 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 28.7M outstanding shares and own 40.56% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3.1M shares), Corvex Management LP (2.47M shares), GOLDMAN SACHS GROUP INC (1.69M shares), Blackstone Inc. (835K shares), MORGAN STANLEY (784K shares), VANGUARD GROUP INC (679K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (643K shares), GAGNON SECURITIES LLC (349K shares), JACOBS LEVY EQUITY MANAGEMENT, INC (314K shares), and BlackRock Inc. (234K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.